This stock is on an overshooting uptrend. Next levels are 1.29$, 2.15$ and 2.75$. The company has a joint venture with Merck and several release candidates passing Phase II.
Trade ist aktiv:
not among pennies.
Kommentar:
1st target reached. ;)
Ähnliche Ideen
Sernova
4Friends3YTyler
about SVA